Dr. Kris Bough is a neuroscientist with interests in early discovery (translational) science, especially as it relates to NIH’s small business program. His research background is in metabolic neuroscience. He has published in the areas of behavioral neuropharmacology, electrophysiology (in vitro and in vivo), molecular biology, neuroanatomy, and, more recently, biomarker identification and development. Dr. Bough earned his M.S. and Ph.D. in Biology from Georgetown University in 1999. He subsequently completed two post-doctoral fellowships in the Department of Neurological Surgery at the University of Washington and the Department of Pharmacology at Emory University. Prior to joining the NIH, he worked three years at the Center for Drug Evaluation and Research (FDA/CDER) as a Pharmacologist. Dr. Bough joined NIDA as a Program Officer working in the Division of Pharmacotherapies and Medical Consequences in February 2008 before moving to what is now the Division of Neuroscience and Behavior (DNB) in April 2013.